There isn’t any current news coming from the Website: http://www.americanbonanza.com
A few trades are being made. Maybe the merger will be beneficial to shareholders. Without much public information doing any analysis is problematic.
October 11, 2013
American Bonanza Suspends Operations at Copperstone Mine
October 11, 2013 - American Bonanza Gold Corp. (TSX: BZA) ("Bonanza" or the "Company") is placing the Copperstone Mine in Arizona on care and maintenance status until further notice. The Company has made this decision in order to cut costs while it reviews operations with a view to improving operational efficiencies, and while it seeks additional capital to fund performance improvements in order to meet designed capacity of the Copperstone Mine. Declining gold prices also factored in the Company's decision to suspend mining and milling operations at this time.
While the suspension of operations may be considered a setback in the Company's goal of achieving commercial production at Copperstone, the Company believes it is necessary in order to achieve that goal. Operating costs have reached unsustainable levels for various reasons. The Company believes that with additional capital, upon the resumption of operations the mine will perform at a consistent mine output rate and mill throughput rate which will help reduce overall costs as the Company moves forward to bring the Copperstone Gold Mine to design operating rates.
The Company is in discussions with a number of potential financing sources which may result in one or more financings in sufficient amounts to enable the Company to bring production at the Copperstone Mine up to design rates. The Company intends to continue these negotiations.
Allon Therapeutics releases first quarter 2013 operating results
Posted on April 29, 2013 by Allon Therapeutics
VANCOUVER, B.C. — Allon Therapeutics Inc. (TSX: NPC) today announced its unaudited operating results for the three months ended March 31, 2013.
During the fourth quarter of 2012, Allon announced that its pivotal clinical trial evaluating its lead product candidate davunetide as a treatment for progressive supranuclear palsy (PSP) failed to demonstrate efficacy in this population. Since that time the Company has been pursuing strategic options for the business to exploit the economic potential of its assets. The Company expects to conclude this process during the second quarter of 2013.
Results of operations
Allon reported a net loss of $1,071,311 ($0.01 per share) for the three months ended March 31, 2013, compared to a net loss of $2,778,704 ($0.03 per share) for the three months ended March 31, 2012, representing a decrease in net loss of $1,707,393. R&D expenses for the three months ended March 31, 2013 were $578,790, consisting primarily of closing costs related to the PSP clinical trial. At March 31, 2013, the Company had cash and cash equivalents of $589,484.
Etame Operator:Vaalco Energy
Water Depth: 137 m / 452 ft
Region: Africa - West Country: Gabon
Last Updated: Apr 17, 2013 (view update history)
Situated in a water depth of 250 feet (76 meters), the Etame field lies within the Etame Marine License in the northern section of the Congo Basin offshore southern Gabon. Serving as operator of the block is VAALCO Energy, holding a 28.07% interest; Addax holds 31.36%; Sasol Petroleum West Africa holds 27.75%; Sojitz Etame Limited holds 2.98%; PetroEnergy Resources Corporation holds 2.34%; and Tullow Oil Gabon holds the remaining 7.5%.
In July 1995, VAALCO Energy was awarded the Etame Marine permit, which encompasses 3,074 square kilometers in the northern basin. Etame was discovered in January 1998 by the Etame-1 well, followed by appraisal drilling in January 1999 by the Etame-2 well, which was deemed non-commercial. The operator then decided to delay further drilling on ...
VAALCO Updates Etame Marin Development Ops
Type: Operator Update
Apr. 2013 - VAALCO announced the successful completion of the EAVOM-3H development well on the Avouma field in the Etame Marin Permit off Gabon. Initially, the well flowed, unassisted, at a rate of 3,000 bopd. That rate was increased to 4,000 bopd once electric submersible pumps (ESP) were engaged. The well will be monitored in the coming weeks to determine the ideal rate of production. KCA Deutag's Ben Rinnes (350' ILC) drilled the well and is currently completing workover activities on the EAVOM-2H and ETBSM-1H wells. Once complete, the rig will mobilize to the Ebouri field where it will drill an exploration appraisal well to evaluate an untested fault block on the south west flank of the field. Additionally, the rig is expected to drill an exploration well on the Mu prospect just north of the Etame field. The objective of the well is to test the Gamba reservoir and the underlying Lucina formation.
Their credit at least with that lender seems to have improved. The terms appear a little better and their overall credit was increased. I'm averaging down in the 7 to 8 area, when stock is available at those levels. It may take a fair amount of time to reap any rewards but they are a viable slow growing company.
When production picks up I would like to know their cost per oz or at least their projected cost.
Cross Atlantic Capital Partners' Initial Venture Capital Fund to Wind Down; Sell Remaining Portfolio Assets
Last update: 3/22/2013 4:02:00 PM
RADNOR, Pa., Mar 22, 2013 (BUSINESS WIRE) -- After a number of successful exits, including three IPOs, Cross Atlantic Capital Partners ("XACP") has announced that it is terminating its vintage 1999 fund, Cross Atlantic Technology Fund, LP ("XATF"). As part of the termination process, XATF is liquidating its remaining portfolio company holdings, including its 668,572 shares of common stock in Rubicon Technology (RBCN).
XACP expects the shares of common stock in RBCN held by XATF to be fully divested by June 30, 2013, although a specific schedule for the sales has not yet been set.
XACP will continue to actively manage Cross Atlantic Technology Fund II and its Co-Investment family of funds, and the sales for XATF will not affect the continuing ownership of the aggregate 4,985,677 shares of common stock and warrants for common stock of RBCN held by these other funds.